RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It also commercializes several legacy products via licensing and distribution partners. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Relief Therapeutics Holding SA?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Relief Therapeutics Holding SA 52 week high is $9.00 as of April 25, 2024.
What is the 52-week low for Relief Therapeutics Holding SA?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Relief Therapeutics Holding SA 52 week low is $1.20 as of April 25, 2024.
What is Relief Therapeutics Holding SA stock price today?
Relief Therapeutics Holding SA stock price today is $1.45.
What was Relief Therapeutics Holding SA stock price yesterday?
Relief Therapeutics Holding SA stock price yesterday was $1.45.
What is the 50-day moving average of Relief Therapeutics Holding SA?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Relief Therapeutics Holding SA 50-day moving average is $1.61.